Table 2.
All regimens (n=1051) | Mifepristone and misoprostol (n=356) | Misoprostol alone (n=593) | Unknown (n=102) | ||
---|---|---|---|---|---|
Age, years | 28·1 (6·0) | 27·5 (6·3) | 28·5 (5·8) | 33·0 (12·7) | |
14 | 2 (<1%) | 2 (1%) | 0 | 0 | |
15–19 | 50 (5%) | 27 (8%) | 17 (3%) | 6 (6%) | |
20–24 | 271 (26%) | 101 (28%) | 136 (23%) | 34 (33%) | |
25–29 | 340 (32%) | 103 (29%) | 214 (36%) | 23 (23%) | |
30–34 | 211 (20%) | 73 (21%) | 116 (20%) | 22 (22%) | |
35–39 | 137 (13%) | 35 (10%) | 89 (15%) | 13 (13%) | |
40–44 | 36 (3%) | 15 (4%) | 18 (3%) | 3 (3%) | |
45–49 | 3 (<1%) | 0 | 2 (<1%) | 1 (1%) | |
50 | 1 (<1%) | 0 | 1 (<1%) | 0 | |
Level of education | |||||
No schooling | 2 (<1%) | 2 (1%) | 0 | 0 | |
Completed primary school | 134 (13%) | 97 (27%) | 14 (2%) | 23 (23%) | |
Completed secondary school | 397 (38%) | 117 (33%) | 248 (42%) | 32 (31%) | |
More than secondary school | 518 (49%) | 140 (39%) | 331 (56%) | 47 (46%) | |
Ascertainment of pregnancy | |||||
Took pregnancy test at home | 700 (67%) | 292 (82%) | 334 (56%) | 74 (73%) | |
Took blood test in a facility | 285 (27%) | 55 (15%) | 205 (35%) | 25 (25%) | |
Took urine test in a facility | 114 (11%) | 2 (1%) | 105 (18%) | 7 (7%) | |
Ultrasound | 113 (11%) | 89 (25%) | 7 (1%) | 17 (17%) | |
Late or missed period | 37 (4%) | 31 (9%) | 1 (<1%) | 5 (5%) | |
Pregnancy symptoms | 13 (1%) | 11 (3%) | 0 | 2 (2%) | |
Other | 1 (<1%) | 0 | 0 | 1 (1%) | |
Duration of pregnancy | 7·0 (2·2) | 7·6 (2·6) | 6·7 (1·8) | 7·0 (1·4) | |
<7 weeks | 518 (49%) | 141 (40%) | 330 (56%) | 47 (46%) | |
7 to <9 weeks | 340 (32%) | 134 (38%) | 174 (29%) | 32 (31%) | |
9 to <12 weeks | 141 (13%) | 50 (14%) | 75 (12%) | 16 (16%) | |
12 to 22 weeks | 52 (5%) | 31 (9%) | 14 (2%) | 7 (7%) |
Data are mean (SD) or n (%).